PARAMETRIC PORTFOLIO ASSOCIATES LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 136 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 2.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2022$49,000
-76.1%
75,584
-59.8%
0.00%
Q4 2021$205,000
-83.5%
188,231
-72.4%
0.00%
-100.0%
Q3 2021$1,243,000
+82.0%
683,102
+164.2%
0.00%
Q2 2021$683,000
+48.5%
258,589
+102.5%
0.00%
Q1 2021$460,000
+146.0%
127,693
+72.5%
0.00%
Q4 2020$187,000
+87.0%
74,033
+86.9%
0.00%
Q3 2020$100,000
-32.4%
39,614
-12.4%
0.00%
Q2 2020$148,000
+15.6%
45,241
-13.6%
0.00%
Q1 2020$128,000
-39.9%
52,359
+16.0%
0.00%
Q4 2019$213,000
+33.1%
45,153
+20.8%
0.00%
Q3 2019$160,000
-1.8%
37,387
+33.5%
0.00%
Q2 2019$163,000
+68.0%
28,011
+10.7%
0.00%
Q1 2019$97,000
+67.2%
25,308
-18.0%
0.00%
Q4 2018$58,000
-14.7%
30,877
+46.1%
0.00%
Q3 2018$68,000
-60.5%
21,129
-62.9%
0.00%
Q2 2018$172,000
-10.9%
56,934
+15.8%
0.00%
Q1 2018$193,000
-76.7%
49,187
-75.4%
0.00%
-100.0%
Q4 2017$827,000
+57.5%
199,677
+133.4%
0.00%0.0%
Q3 2017$525,000
-1.5%
85,569
-0.1%
0.00%0.0%
Q2 2017$533,000
+3.7%
85,676
+5.8%
0.00%0.0%
Q1 2017$514,000
+403.9%
81,011
+325.7%
0.00%
Q4 2016$102,000
-2.9%
19,032
+2.3%
0.00%
Q3 2016$105,000
-80.5%
18,600
-81.0%
0.00%
-100.0%
Q2 2016$538,000
+214.6%
97,985
+325.2%
0.00%
Q1 2016$171,000
-2.8%
23,042
+8.9%
0.00%
Q4 2015$176,000
-18.9%
21,152
-12.0%
0.00%
Q3 2015$217,000
-15.6%
24,045
+12.2%
0.00%
-100.0%
Q2 2015$257,000
-63.4%
21,431
-67.2%
0.00%0.0%
Q1 2015$703,000
+66.2%
65,320
-21.7%
0.00%0.0%
Q4 2014$423,000
+93.2%
83,400
+0.4%
0.00%
Q3 2014$219,000
-37.8%
83,053
-4.8%
0.00%
-100.0%
Q2 2014$352,000
-56.7%
87,220
-50.9%
0.00%
-50.0%
Q1 2014$813,000
+44.9%
177,521
+37.3%
0.00%
+100.0%
Q4 2013$561,000
+87.6%
129,307
+70.3%
0.00%0.0%
Q3 2013$299,000
+251.8%
75,951
+89.1%
0.00%
Q2 2013$85,00040,1610.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2018
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$51,946,0002.80%
MILLER VALUE PARTNERS, LLC 4,900,721$26,219,0001.15%
MSD Partners, L.P. 3,410,500$18,246,0000.92%
Michael & Susan Dell Foundation 66,749$357,0000.26%
Glacier Peak Capital LLC 68,043$364,0000.21%
Vident Investment Advisory, LLC 114,980$615,0000.08%
SFMG, LLC 62,433$334,0000.07%
Virtus ETF Advisers LLC 40,359$216,0000.06%
Steward Partners Investment Advisory, LLC 23,187$124,0000.06%
O'Dell Group, LLC 10,142$54,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders